The Division of Allergy and Immunology at Washington University School of Medicine initiates and participates in a wide range of clinical research efforts to evaluate the safety and efficacy of promising new treatment options for various types of asthma, allergies and immunological diseases.
Among the clinical studies are those that focus on asthma, urticaria (hives or itch), food allergies (e.g. Alpha-gal), and rarer diseases such as hereditary angioedema and primary immunodeficiency disease. Scientific research related to the human microbiome and its role in asthma as well as in urinary tract infections also are under way.
In addition, our doctors are studying allergic reactions to the COVID-19 vaccines. The various investigations include those under the auspices of the National Institutes of Health and those supported by the division or pharmaceutical companies.
Are you interested in participating in a clinical trial?
Review our list of current trials below and contact us for more information.
Tarisa Mantia
Manager, Division Clinical Research
314-996-8339
Tmantia@wustl.edu